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eural stem cell (NSC) differentiation is precisely
controlled by a network of transcription factors,
which themselves are regulated by extracellular
signals (Bertrand, N., D.S. Castro, and F. Guillemot. 2002.
 
Nat. Rev. Neurosci.
 
 3:517–530; Shirasaki, R., and S.L. Pfaff.
2002. 
 
Annu. Rev. Neurosci.
 
 25:251–281). One way that
the activity of such transcription factors is controlled is by
the regulation of their movement between the cytosol and
nucleus (Vandromme, M., C. Gauthier-Rouviere, N. Lamb,
and A. Fernandez. 1996. 
 
Trends Biochem. Sci
 
. 21:59–64;
Lei, E.P., and P.A. Silver. 2002. 
 
Dev. Cell
 
. 2:261–272). Here
N
 
we show that the basic helix–loop–helix transcription factor
OLIG2, which has been shown to be required for motor
neuron and oligodendrocyte development, is found in the
cytoplasm, but not the nucleus, of astrocytes in culture and
of a subset of astrocytes in the subventricular zone. We
demonstrate that the accumulation of OLIG2 in the nucleus
of NSCs blocks the CNTF-induced astrocyte differentiation
and that the translocation of OLIG2 to the cytoplasm is pro-
moted by activated AKT. We propose that the AKT-stimulated
export of OLIG2 from the nucleus of NSCs is essential for
the astrocyte differentiation.
 
Introduction
 
OLIG2 is a basic helix–loop–helix (bHLH) transcription fac-
tor required for oligodendrocyte development (Lu et al.,
2000; Takebayashi et al., 2000; Zhou et al., 2000, 2001).
OLIG2 also blocks astrocyte differentiation, by inhibiting
complex formation between STAT3 and the transcription
coactivator p300 (Lu et al., 2002; Takebayashi et al., 2002;
Zhou and Anderson 2002; Gabay et al., 2003; Fukuda et
al., 2004). Despite the crucial role of OLIG2 in glial fate
decision, little is known about how OLIG2 itself is regu-
lated during glial development. Previous findings have
suggested that when neural stem cells (NSCs) begin to dif-
ferentiate into glial–fibrillary–acidic–protein (GFAP)-posi-
tive astrocytes in culture, OLIG2 disappears from the nu-
cleus and is sometimes detected in the cytoplasm (Fukuda
et al., 2004), raising the possibility that the translocation
of OLIG2 from the nucleus to cytoplasm might be crucial
for astrocyte differentiation.
Here we show that OLIG2 is detected in the cytoplasm
of GFAP-positive astrocytes in the subventricular zone
(SVZ) of adult mouse brain, which have been shown to act
as NSCs that give rise to both neurons and glia. We dem-
onstrate that Leptomycin B (LMB), which is a specific in-
hibitor of CRM1-dependent nuclear export (Fornerod et
al., 1997; Yoshida and Horinouchi, 1999), blocks both the
export of OLIG2 from the nucleus and astrocyte differen-
tiation  induced by ciliary neurotrophic factor (CNTF).
Moreover, we show that an OLIG2 mutant lacking a pu-
tative CRM1 binding site is deficient in both CNTF-
induced nuclear export and astrocyte differentiation. Finally,
we show that AKT, which is activated by CNTF stimula-
tion, phosphorylates OLIG2 in vitro and that an OLIG2
mutant lacking an AKT phosphorylation site is also defi-
cient in both CNTF-induced nuclear export and astrocyte
differentiation. These findings suggest that AKT-depen-
dent nuclear export of OLIG2 plays a crucial part in astro-
cyte differentiation.
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Results and discussion
 
Export of OLIG2 from the nucleus is essential for 
astrocyte differentiation
 
We first investigated whether OLIG2 localized in the cyto-
plasm of astrocyte in vivo. We immunolabeled sections of ei-
ther newborn or adult mouse brain for both OLIG2 and a
neural marker—SSEA1 for NSCs, neurofilament (NF) for
neurons, or GFAP for astrocytes. In the SVZ of the adult
brain, 44% of the cells with OLIG2 in the nucleus stained
for SSEA1, and 38% stained for NF (Fig. 1, a and b). None
of GFAP-positive cells had OLIG2 in the nucleus, although
20% of them had OLIG2 in the cytoplasm (Fig. 1 c). In the
ventricular zone (VZ) of the newborn brain, we also found
that 57% of the cells with OLIG2 in the nucleus stained for
SSEA1, and 41% stained for NF; none of GFAP-posi-
tive cells had OLIG2 in the nucleus, although 4% of them
had OLIG2 in the cytoplasm (unpublished data). It seems,
therefore, that, in the VZ and SVZ, OLIG2 is mainly in the
nucleus of both NSCs and neurons, by contrast, the few as-
trocytes contained OLIG2 exclusively in their cytoplasm.
We investigated further the relationship between OLIG2
localization and astrocyte differentiation in culture. We pre-
pared NSCs from embryonic mouse telencephalon and ex-
panded them in both basic FGF (bFGF) and EGF for 2 wk.
Over 90% of the NSCs were OLIG2-positive by 2 wk
(Fukuda et al., 2004). To induce astrocyte differentiation, we
withdrew both the bFGF and EGF and added CNTF
(Fukuda et al., 2004). We used LMB to block active export
from the nucleus. After 2 d in CNTF, over 50% of the cells
differentiated into GFAP-positive astrocytes; none of the
GFAP-positive cells had OLIG2 in their nucleus (Fig. 2 a),
but 10% had OLIG2 in their cytoplasm (Fig. 2, a and b). By
contrast, the GFAP-negative cells still had OLIG2 in their
nucleus (Fig. 2 a), and these cells stained for Nestin that is a
marker for NSCs (Fig. 2 d). After 4 d, 90% of the cells were
GFAP-positive and OLIG2-negative (not shown). After 2 d
in CNTF plus LMB, compared with the NSCs cultured in
CNTF alone for 2 d, NSC proliferation had significantly de-
creased, the cell bodies had become larger, over 95% of the
cells were GFAP-negative and had OLIG2 in the nucleus
(Fig. 2 c). These findings suggest that CNTF-induced astro-
cyte differentiation is associated with CRM1-dependent trans-
location of OLIG2 from the nucleus into the cytoplasm.
Because it was shown previously that STAT3 accumulates
in the nucleus when NSCs are induced by CNTF/LIF to ex-
press GFAP (Bonni et al., 1997; Nakashima et al., 1999), we
examined STAT3 localization in NSCs cultured in either
Figure 1. Evidence of OLIG2 translocation 
from the nucleus of astrocytes in the SVZ of adult 
mouse brain. Brain sections of adult mice were 
labeled for both OLIG2 (green) and a neural marker 
(red); (a) SSEA1, (b) NF, or (c and d) GFAP. The 
sections were counterstained with Hoechst 33342 
(blue). Arrowheads and arrows show OLIG2-positive 
cells in the nucleus and in the cytoplasm, respec-
tively. V shows ventricle. Bars, 10  m.
Figure 2. Translocation of nuclear 
proteins from the nucleus is required for 
CNTF-induced astrocyte differentiation. 
(a, b, d, and e) NSCs cultured in either 
CNTF alone or (c and f) CNTF plus LMB 
for 2 d were labeled for OLIG2 (green) 
and (a–c) GFAP (red), OLIG2 (green), 
and (d) Nestin (red), or (e and f) STAT3 
(green) and GFAP (red). The cells were 
counterstained with Hoechst 33342 
(blue). Arrowhead shows OLIG2-positive 
cells in the cytoplasm. Bar, 25  m. 
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CNTF alone or CNTF plus LMB. After 2 d in CNTF
alone, STAT3 was mainly in the nucleus, and 
 
 
 
50% of the
cells stained for GFAP, and many looked like astrocytes
(Fig. 2 e). By contrast, after 2 d in CNTF plus LMB,
STAT3 strongly accumulated in the nucleus, but none of
the cells were GFAP positive and acquired an astrocytic mor-
phology (Fig. 2 f). Thus, nuclear accumulation of STAT3 is
apparently not enough to induce astrocyte differentiation;
nuclear export of transcriptional repressors such as OLIG2
may also be required.
 
CNTF-dependent OLIG2 translocation from the 
nucleus depends on CRM1
 
Because it seemed likely that OLIG2 export from the nu-
cleus would depend on the nuclear export signal receptor
CRM1, we looked for CRM1-binding sites in OLIG2. We
found one putative nuclear export signal sequence (NES;
146-LSKIATLLL-154). To examine whether this sequence
was a functional NES, we replaced the leucines at 152 and
154 to alanines and examined the localization of the mu-
tant protein in Cos7 cells. When FLAG-tagged wild-type
OLIG2 (OLIG2-w) was overexpressed in Cos7 cells, it was
diffusely distributed (Fig. 3 a), although in the presence of
LMB it accumulated in the nucleus (Fig. 3 b), suggesting
that OLIG2 is normally exported from the nucleus by
CRM1 in Cos7 cells. By contrast, when FLAG-tagged mu-
tant OLIG2 (OLIG2–NES) was expressed in Cos7 cells, it
accumulated in the nucleus even in the absence of LMB
(Fig. 3 c), confirming that 146-LSKIATLLL-154 is the rele-
vant CRM1-dependent export signal in OLIG2.
Because it has been shown that enforced expression of
OLIG2-w does not block CNTF-induced astrocyte differen-
tiation completely (Fukuda et al., 2004), we examined
whether OLIG2–NES would be more effective at blocking
CNTF-induced astrocyte differentiation. We overexpressed
OLIG2–NES in NSCs, cultured them in the presence of
CNTF for 2 d, and then immunolabeled them for GFAP.
Whereas 
 
 
 
50% of the cells transfected with a control vector
and 35% of the cells transfected with OLIG2-w were labeled
for GFAP (Fig. 3, d and f; and data not depicted), 
 
 
 
10%
of the cells transfected with OLIG2–NES were labeled for
GFAP (Fig. 3, e and f). Together with the previous findings
(Fukuda et al., 2004), these results suggest that CRM1-
dependent OLIG2 translocation from the nucleus is crucial
for CNTF-induced astrocyte differentiation.
It has been shown that the nuclear corepressor N-CoR,
which inhibits astrocyte differentiation, is also exported
from the nucleus, following CNTF stimulation (Hermanson
et al., 2002), raising the possibility that OLIG2 and N-CoR
may be physically associated. When we immunolabeled
cultured NSCs with anti N-CoR antibodies, 
 
 
 
10% of the
cells showed nuclear staining (Fig. 4 a). CNTF stimulation
caused the N-CoR to translocate to the cytoplasm (Fig. 4 b),
as reported previously (Hermanson et al., 2002). However,
we detected OLIG2 in the nucleus of 
 
 
 
90% of the cultured
NSCs (Fukuda et al., 2004), making it unlikely that OLIG2
is associated with N-CoR in the cells. To test this conclusion
further, we transfected either a control vector expressing
GFP or a vector expressing OLIG2–NES, cultured them in
Figure 3. Nuclear accumulation of OLIG2 blocks astrocyte 
differentiation. (a–c) Cos7 cells were transfected with either (a and b) 
FLAG-tagged OLIG2-w or (c) FLAG-tagged OLIG2–NES. (b) LMB 
was used to block active export from the nucleus. Transfected 
OLIG2 was detected with anti-FLAG antibody (green) and the cells 
were counterstained with PI (red). NSCs were transfected with either 
(d) the control vector or (e) OLIG2–NES, cultured in CNTF, and 
labeled for (d) either GFP (green) and GFAP (red) or (e) FLAG (green) 
and GFAP (red). Arrowheads show the transfected cells. (f) The pro-
portions of GFAP positive cells in transfected cells are shown as the 
mean   SD of three cultures. *, P   0.01 by t test. Bars: (a–c) 50  m; 
(d and e) 25  m. 
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CNTF for 2 d, and then immunolabeled them for N-CoR
and either GFP or FLAG. In the cells transfected with either
the control vector or the OLIG2–NES vector, N-CoR was
detected only in the cytoplasm (Fig. 4, c and d), whereas
OLIG2–NES remained in the nucleus (Fig. 4 d). It seems,
therefore, that OLIG2 and N-CoR independently regulate
astrocyte differentiation.
 
CNTF stimulated PI-3 kinase (PI3K)/AKT activation 
induces OLIG2 translocation from the nucleus
 
It was shown previously that CNTF can activate PI3K, as
well as STAT3 (Alonzi et al., 2001). Moreover, the PI3K in-
hibitor LY294002 blocks both CNTF-induced astrocyte dif-
ferentiation and CNTF-induced N-CoR translocation from
the nucleus (Hermanson et al., 2002). As we could not detect
N-CoR in the nucleus of most of our cultured NSCs (Fig. 4
a), we tested whether PI3K signaling also regulates OLIG2
localization. We cultured NSCs in the presence of either
CNTF alone or CNTF plus LY294002 for 3 d and then im-
munolabeled the cells for both OLIG2 and an astrocyte
marker (either GFAP or S100
 
 
 
). In CNTF alone, 
 
 
 
70% of
NSCs differentiated into GFAP-positive and S100
 
 
 
-positive
astrocytes, which had lost OLIG2 from the nucleus (Fig. 5, a
and c; and online supplemental material available at http://
www.jcb.org/cgi/content/full/jcb.200404104/DC1). 10%
of either GFAP-positive or S100
 
 
 
-positive cells still had
OLIG2 in the cytoplasm. 20% of the cells retained OLIG2
in their nucleus, and all of them were GFAP negative (Fig. 5
a). By contrast, in the presence of CNTF and LY294002,
 
 
 
90% of the cells were GFAP negative and S100
 
 
 
 negative
and retained OLIG2 in the nucleus (Fig. 5, b and c; and on-
line supplemental material available at http://www.jcb.org/
cgi/content/full/jcb.200404104/DC1). Thus, PI3K signal-
ing in cultured NSCs apparently promotes OLIG2 transloca-
tion from the nucleus and is crucial for CNTF-induced as-
trocyte differentiation.
Because AKT kinase is a major target of PI3K signaling
(Hunter, 2000; Schlessinger, 2000), we looked for AKT
phosphorylation sites in OLIG2 and found one (26-SKG-
GSSSGF-34) centered at serine 30. To examine whether
AKT phosphorylates OLIG2 directly, we overexpressed
either FLAG-tagged OLIG2-w or a FLAG-tagged mutant
OLIG2 in which serine 30 was replaced by alanine (OLIG2-
S30A) in NSCs, purified the proteins using anti-FLAG anti-
body, and then used the proteins in an in vitro kinase assay.
Whereas OLIG2-w was phosphorylated by AKT, OLIG2-
S30A was not, suggesting that serine 30 in OLIG2 is a direct
target of AKT (Fig. 5 d).
To investigate the relationship between AKT-dependent
OLIG2 phosphorylation and OLIG2 localization, we over-
expressed the OLIG2-w or OLIG2-S30A in Cos7 cells and
stained them for FLAG. Whereas OLIG2-w was detected
mainly in the cytoplasm (Fig. 5 e), OLIG2-S30A was de-
tected mainly in the nucleus (Fig. 5 f), suggesting that the
translocation of OLIG2 from the nucleus depends on AKT-
dependent phosphorylation of serine 30. We then examined
whether OLIG2-S30A can block astrocyte differentiation.
We overexpressed OLIG2-S30A in NSCs, cultured them in
the presence of CNTF for 2 d, and then labeled them for
GFAP. Whereas 
 
 
 
50% of the cells transfected with the con-
trol vector differentiated into GFAP-positive astrocytes (Fig.
5, g and i), 
 
 
 
5% of the cells expressing OLIG2-S30A did so
(Fig. 5, h and i), suggesting that AKT-dependent trans-
location of OLIG2 from the nucleus is essential for CNTF-
induced astrocyte differentiation. Interestingly, BMPs also
promote astrocyte differentiation, and they can activate both
STAT3 and AKT (D’Alessandro et al., 1994; Gross et al.,
1996; Ghosh-Choudhury et al., 2002; Rajan et al., 2003).
In the developing spinal cord, OLIG2 is expressed only
in the ventral VZ, where motor neurons and oligodendro-
cytes, but not astrocytes, are generated (Lu et al., 2000;
Takebayashi et al., 2000; Zhou et al., 2000). It therefore
seems unlikely that the mechanism of nuclear-to-cytoplasm
translocation of OLIG2 that we describe here is relevant for
astrocyte differentiation in the spinal cord. However, we
found that OLIG2 localized in the cytoplasm of GFAP-
positive astrocytes in both the VZ of newborn mouse brain
and SVZ of adult mouse brain, suggesting that the translo-
cation of OLIG2 from the nucleus might operate in astro-
cyte differentiation in the brain. Moreover, once VZ/SVZ
cells are dissociated and expanded in culture, independently
of their origins, they start to express OLIG2, proliferate in-
definitely, and generate neurons, astrocytes and oligoden-
drocytes (Gabay et al., 2003; Fukuda et al., 2004). Recent
evidence has also shown that the inhibition of OLIG2 ac-
tivity in cultured NSCs blocks their proliferation and in-
duces astrocyte differentiation (Hack et al., 2004). Since
nuclear accumulation of OLIG2 is crucial to block astro-
cyte differentiation in cultured NSCs, these findings sug-
gest that translocation of OLIG2 from the nucleus on its
own might be sufficient to induce astrocyte differentiation
in cultured NSCs.
Such NSCs are an attractive potential source of neural
cells for cell therapy, as it has been shown that they can pro-
mote functional recovery in various types of CNS damage
(Cao et al., 2002; Okano, 2002; Hallbergson et al., 2003).
Hence, it will be important to understand the regulation of
OLIG2 in NSCs, especially as there is another evidence that
oligodendrocyte precursor cells in the adult brain can behave
as NSCs (Nunes et al., 2003).
Figure 4. Localization of OLIG2 and N-CoR is regulated indepen-
dently. NSCs were cultured in either (a) bFGF plus EGF or (b) CNTF 
alone, and then labeled for N-CoR (red). Arrowheads show N-CoR–
positive cells in the nuclei. NSCs were transfected with either (c) the 
control vector or (d) OLIG2–NES, cultured in the presence of CNTF, 
and then (c) labeled for either GFP (green) and N-CoR (red) or (d) 
FLAG (green) and N-CoR (red). The cells were counterstained with 
Hoechst 33342 (blue). Bars: 25  m. 
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Materials and methods
 
Mice and cell culture
 
All animal procedures were performed according to the guidelines of the
University of Cambridge Centre for Brain Repair. Neuroepithelial cells
were isolated from telencephalons of E14.5 CD1 mice and expanded for up
to 4 wk in N2-supplemented DME/F-12 containing 10 ng/ml bFGF (Pepro-
tech) and 10 ng/ml EGF (Peprotech) as described previously (Nakashima et
al., 1999). Recombinant CNTF (Peprotech) was used for the induction of
astrocytes at a concentration of 20 ng/ml. Cos7 cells were maintained in
DME supplemented with 10% FCS. In some experiments, LMB (25 ng/ml;
Sigma-Aldrich) and LY294002 (50 
 
 
 
M; Calbiochem) were used to inhibit
CRM1-dependent nuclear export and PI3 kinase activity, respectively.
 
Immunochemistry
 
Newborn and adult CD1 mice (P35w) were killed under deep anesthesia
and 10-
 
 
 
m frozen sections of the brain were prepared. Sections were
treated with acetone at 
 
 
 
20
 
 
 
C for 20 min and 70% ethanol at 
 
 
 
20
 
 
 
C for
10 min, blocked with 10% FCS at room temperature for 1 h. Cultured cells
were labeled as described previously (Fukuda et al., 2004). The following
antibodies were used to detect antigens: mouse anti-NF (1:200; Chemi-
con), mouse anti-GFAP (1:200; Sigma-Aldrich), rabbit anti-GFAP antibod-
ies (1:500; DakoCytomation), mouse anti-S100
 
 
 
 antibody (1:500; Sigma-
Aldrich), mouse anti-SSEA1 (1:20; Santa Cruz Biotechnology Corp.), and
rabbit anti-OLIG2 antibodies (1:2,000; gift from H. Takebayashi, National
Institute for Physiological Sciences, Okazaki, Japan), rabbit anti-STAT3 an-
tibodies (1:200; Santa Cruz Biotechnology Corp.), rabbit anti-N-CoR anti-
bodies (1:200; Santa Cruz Biotechnology Corp.), mouse anti-GFP antibody
(1:200; Molecular Probe), mouse anti-FLAG M2 antibody (1:200; Sigma-
Aldrich), or their combinations, followed by Alexa-dye–conjugated sec-
ondary antibodies (1:200; Molecular Probe) or Texas red–conjugated anti–
mouse IgM (1:200; Jackson ImmunoResearch Laboratories), and finally
stained with propidium iodide (PI; 1 
 
 
 
g/ml) or Hoechst dye 33342 (1 
 
 
 
g/
ml; Molecular Probe) to visualize all nuclei. The stained sections or cells
were mounted in Citifluor mounting medium (CitiFluor). The fluorescence
images were acquired using an upright fluorescence microscope (model
LeiTZDMRD; Leica), a CCD camera (model C4742-95; Hamamatsu), 40
 
 
 
and 60
 
 
 
 objectives, and an OpenLab software (Improvision). Images were
combined for figures using Adobe Photoshop 5.5.
 
Transfection
 
Transfection into NSCs was performed using the Nucleofector according to
the supplier’s instruction (amaxa). On the following day, the cells were har-
vested and recultured on poly-L-ornithine (15 
 
 
 
g/ml; Sigma-Aldrich) and fi-
bronectin (1 
 
 
 
g/ml; Invitrogen) -coated eight-well chamber slide (Nunc) as
described before (Nakashima et al., 1999). The cells were then induced to
differentiate into astrocytes. Transfection into Cos7 cells was performed us-
ing the Superfect Transfection Reagent according to the supplier’s instruc-
tion (QIAGEN). On the following day, the cells were harvested and recul-
tured on coverslips for another 2 d before immunolabeling.
 
Vector constructs
 
The expression vector of OLIG2-w (FLAG–OLIG2–pcDNA3) was de-
scribed before (Fukuda et al., 2004). Mutant form of OLIG2 with the dele-
tion of either NES or AKT phosphorylation site was made using AccuTaq
LA DNA polymerase (Sigma-Aldrich) and sets of oligonucleotides contain-
ing mutant sequence. The following oligonucleotide DNA primers were
synthesized: for the full-length mouse 
 
olig2
 
 cDNA, the 5
 
 
 
 primer was 5
 
 
 
-
TTGAATTCATGGACTCGGACGCCAGCCT-3
 
 
 
, and the 3
 
 
 
 primer was 5
 
 
 
-
AACTCGAGTCACTTGGCGTCGGAGGTGAG-3
 
 
 
. For a mutant in the NES,
the sense primer was 5
 
 
 
-ACGGCGCTGGCGGCGCGAAACTACATC-3
 
 
 
,
and the anti-sense primer was 5
 
 
 
-CGCCGCCAGCGCCGTGGCGATCT-
TGGA-3
 
 
 
. For a mutant in the AKT phosphorylation site, the sense primer
was 5
 
 
 
-AGCAAGGGGGGAGCCAGCAGCGGCTT-3
 
 
 
, and the anti-sense
primer was 5
 
 
 
-AAGCCGCTGCTGGCTCCCCCCTTGCT-3
 
 
 
. The mutant
cDNAs were fused with FLAG in the pcDNA3 expression vector (Invitro-
gen) as described previously (Fukuda et al., 2004), resulting in FLAG–
OLIG2–NES–pcDNA3 (OLIG2–NES) and FLAG–OLIG2–S30A–pcDNA3
(OLIG2–S30A). pIRES-EGFP (Becton Dickinson) was used as a control
vector.
 
In vitro kinase assay
 
The in vitro kinase assay was performed following the instructions of the
supplier (Cell Signaling Technology). In brief, we transfected 10 
 
 
 
g of either
OLIG2-w or OLIG2-S30A to 5 
 
  
 
10
 
6
 
 NSCs using Nucleofector (amaxa). 2 d
later, the transfected NSCs were harvested and suspended in cell lysis buffer
(Cell Signaling Technology). The cells were sonicated briefly and cell debris
was removed by centrifugation. The proteins were immunoprecipitated us-
ing anti-FLAG antibody and protein A–Sepharose (Amersham Bioscience),
Figure 5. PI3K/AKT signaling contrib-
utes to astrocyte differentiation by 
inducing nuclear export of OLIG2. 
NSCs were cultured in (a) CNTF alone 
or (b) CNTF plus LY294002, and then 
stained for OLIG2 (green) and GFAP 
(red) and with Hoechst 33342 (blue). 
(c) The proportions of GFAP-positive 
cells in CNTF alone and CNTF plus 
LY294002 are shown as the mean   SD 
of three cultures. *, P   0.001 by t test. 
(d) Either OLIG2-w or OLIG2-S30A was 
overexpressed in NSCs, purified using 
anti-FLAG antibody, and then used for 
the in vitro AKT kinase reaction. The 
reaction mixture was analyzed using 
anti-phospho AKT substrate antibody. 
Cos7 cells were transfected with (e) 
FLAG-tagged OLIG2-w or (f) OLIG2-
S30A. Transfected OLIG2 was detected 
with anti-FLAG antibody (green) and the 
cells were counterstained with PI (red). 
NSCs were transfected with either (g) the 
control vector or (h) OLIG2-S30A, cul-
tured in CNTF, and then (g) labeled for 
either GFP (green) and GFAP (red) or (h) 
FLAG (green) and GFAP (red). Arrow-
heads show the transfected cells. (i) The 
proportions of GFAP-positive cells in 
transfected cells are shown as the mean   
SD of three cultures. *, P  0.01 by t test. 
Bars: (a and b) 50  m; (e–h) 25  m. 
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washed twice in the lysis buffer and three times in the AKT kinase buffer,
and were subjected for AKT kinase assay following supplier’s instructions
(Cell Signaling Technology). The reactions were quenched by addition of
SDS-PAGE buffer and analyzed using Western blotting and anti-phospho-
AKT substrate antibody (Cell Signaling Technology).
 
Online supplemental material
 
Figure S1 shows that PI3K inhibitor LY294002 blocks both S100
 
 
 
 expression
and nuclear export of OLIG2 induced by CNTF. Online supplemental materi-
als are available at http://www.jcb.org/cgi/content/full/jcb.200404104/DC1.
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